Navigation Links
Mendel Biotechnology to sell its subsidiary, Mendel Plant Sciences
Date:9/4/2013

HAYWARD, Calif., Sept. 4, 2013 /PRNewswire/ -- Mendel Biotechnology Inc. ("MBI"), a leading agricultural discovery company, is announcing its intention to sell its operating subsidiary, Mendel Plant Sciences ("Mendel" or "the Company"). Mendel Biotechnology Inc. will continue to operate its royalty-based, biotech trait business developed primarily in collaboration with Monsanto. The separation of the two distinct businesses will enable each to maximize their respective value.

Mendel's knowledge of the 'Plant Gene Regulatory Networks', that control crop productivity processes, is a direct result of more than $100 million invested in research and development. This investment in people and facilities has generated advanced technologies, including Mendel's Productivity Reporter Panel, a proprietary screening system, new biotech traits and novel herbicide candidates.  Mendel has discovered performance chemistries and biostimulants that enhance crop productivity through improved drought tolerance, water use, disease resistance and photosynthesis. 

Neal Gutterson, President and CEO of MBI, said: "We have made tremendous progress at Mendel, generating new technologies for improving plant growth and performance through both seed and agrochemical products. We believe that our technologies can help shape the future of the agricultural industry".

MBI has engaged Kirchner Group, a leading mid-market M&A firm with expertise in the agriculture and food industries, to advise the Board and lead the acquisition process.  "The Board of Directors feels that the Company can best achieve its full potential within the context of a larger organization that has a complementary strategic focus.  In this way, it could fully realize its commercial opportunities within the billion-dollar markets that its platform creates," explained Gutterson. Interested parties should contact Kirchner Group.

About Mendel Biotechnology

Mendel Biotechnology Inc., headquartered in Hayward, California, is a leading plant science company meeting the needs of global agriculture. Since 1997, Mendel has been deploying its plant gene regulatory network platform and proprietary tools to improve productivity, resource use efficiency and stress tolerance of key agriculture crops. Mendel's platform has already identified technologies for next-generation yield traits in soybean and other crops, and is the foundation of a pioneering class of crop performance chemistries and novel herbicides. For more information, visit: www.mendelbio.com

About Kirchner Group

The Kirchner Group has been providing traditional merchant banking services since 1985. The Company provides operational and transactional support for companies and asset management services for institutional investors. Kirchner Group's proprietary platform is built on the premise that pairing deep domain expertise with process experts provides superior results. Our clients and partners range from some of the most promising entrepreneurs, to fortune 500 companies and their investors. In addition, Kirchner Group manages assets on behalf of some of the largest insurance companies, commercial banks and institutional investors in the world. www.kirchnergroup.com

Contact:

Kirchner Group

Clete Walker, Managing Director             (205)515-5401

Email: cwalker@kirchnergroup.com

 


'/>"/>
SOURCE Mendel Biotechnology Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. DuPont Pioneer and Mendel Biotechnology, Inc. Collaborate to Improve Water Use Efficiency and Photosynthesis in Corn
2. Quantason Names Dr. Ellen B. Mendelson, Medical Director
3. Commercial Biotechnology Separation Systems Market Analyzed in New Research Report at ReportsnReports.com
4. The Zacks Analyst Blog Highlights: SPDR Health Care Select Sector Fund, SPDR S&P 500, SPDRS&P Biotech ETF, PowerShares S&P SmallCap Health Care Portfolio and PowerShares Dynamic Biotechnology & Genome Portfolio
5. Public Offerings of Common Stock, Financial Results, and Significant Progress in Key Development Programs - Research Report on BioCryst, Exelixis, Idenix, Puma Biotechnology, and Halozyme
6. Sanguine BioSciences Announces Distribution Partnership with AMS Biotechnology
7. Biotech & BioPharma Professionals: CA Board of Pharmacy Executive, Virginia Herold, to Deliver Keynote at BSMA Annual Biotechnology Conference Oct 8-9
8. Biotechnology (BSMA) Conference For Supply Chain Professionals Returns To Foster City, October 8-9, 2013
9. Plant Biotechnology Companies Begin New Conversation about GMOs and How our Food is Grown
10. Nobel Laureate Dr. Oliver Smithies to Deliver Plenary Session at ISPE Biotechnology Symposium
11. TriMix for Travel Now Available at KRS Global Biotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... a new line of intelligent tools designed, tuned and optimized exclusively for Okuma ... 12–17 in Chicago. The result of a collaboration among several companies with expertise ...
(Date:6/22/2016)... June 22, 2016 Research and Markets has ... report to their offering. ... 2014 from $29.3 billion in 2013. The market is expected to ... from 2015 to 2020, increasing from $50.6 billion in 2015 to ... forecasts during the forecast period (2015 to 2020) are discussed. As ...
(Date:6/22/2016)... 2016   ViaCyte, Inc. , a privately-held regenerative ... replacement therapy for the treatment of diabetes in clinical-stage ... Meeting.  ISSCR 2016, the Global Stem Cell Event, is ... in San Francisco.    ... follows:Event: , Focus Session: Tools for Basic and Applied ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
Breaking Biology News(10 mins):